Changchun Bcht Biotechnology Co. Class ASSE: 688276

Announcement on Voluntary Disclosure of Approval of Clinical Trial Application for Adsorbed Acellular DTPa (Dual-component) Combined Vaccine (for Adults and Adolescents)

· Issued by Changchun Bcht Biotechnology Co. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Approval of Clinical Trial Application for Adsorbed Acellular DTPa (Dual-component) Combined Vaccine (for Adults and Adolescents)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis